drugset / Trial / NCT05435755
Precise Transplantation of hAESCs Into the Ventricle for Parkinson's Disease.
Phase 0
Unknown
12 enrolled
Shanghai East Hospital
Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety of multiple treatments of hAESCs treatments, while exploring the effectiveness of hAESCs treatments for PD.
Timeline
- Start
- 2022-12-02
- Primary completion
- 2023-07-30
- Completion
- 2023-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | hAESCs | Cell therapy | 5e+07 cells | Other |